Early assessment of the impact of mitigation measures to control COVID-19 in 22 French metropolitan areas, October to November 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
12 2020
Historique:
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 29 12 2020
Statut: ppublish

Résumé

In France, measures including curfew and lockdown were implemented to control the COVID-19 pandemic second wave in 2020. This study descriptively assesses their possible effects, also relative to their timing. A considerable decrease in incidence of COVID-19 cases and hospital admissions was observed 7 to 10 days after mitigation measures were put in place, occurring earlier in metropolitan areas which had implemented these first. This temporal coincidence suggests the measures' positive impact, consistent with international experiences.

Identifiants

pubmed: 33334399
doi: 10.2807/1560-7917.ES.2020.25.50.2001974
pmc: PMC7812421
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Med Internet Res. 2020 Jul 22;22(7):e19904
pubmed: 32658858
Lancet. 2020 Oct 10;396(10257):1068-1069
pubmed: 33007219
Swiss J Econ Stat. 2020;156(1):10
pubmed: 32864361
Science. 2020 Jul 10;369(6500):
pubmed: 32414780
Lancet Public Health. 2020 Jul;5(7):e375-e385
pubmed: 32502389
Nature. 2008 Apr 10;452(7188):750-4
pubmed: 18401408
Nat Hum Behav. 2020 Dec;4(12):1303-1312
pubmed: 33199859

Auteurs

Guillaume Spaccaferri (G)

Santé publique France, Saint-Maurice, France.
These authors contributed equally to this article and share first authorship.

Sophie Larrieu (S)

Santé publique France, Saint-Maurice, France.
These authors contributed equally to this article and share first authorship.

Jérôme Pouey (J)

Santé publique France, Saint-Maurice, France.

Clémentine Calba (C)

Santé publique France, Saint-Maurice, France.

Thomas Benet (T)

Santé publique France, Saint-Maurice, France.

Cécile Sommen (C)

Santé publique France, Saint-Maurice, France.

Daniel Lévy-Bruhl (D)

Santé publique France, Saint-Maurice, France.

Sabira Smaili (S)

Santé publique France, Saint-Maurice, France.

Didier Che (D)

Santé publique France, Saint-Maurice, France.

Laurent Filleul (L)

Santé publique France, Saint-Maurice, France.

Céline Caserio-Schönemann (C)

Santé publique France, Saint-Maurice, France.

Fatima Ait-El-Belghiti (F)

Santé publique France, Saint-Maurice, France.

Sylvie Haeghebaert (S)

Santé publique France, Saint-Maurice, France.

Jean-Claude Desenclos (JC)

Santé publique France, Saint-Maurice, France.

Laëtitia Huiart (L)

Santé publique France, Saint-Maurice, France.

Anne Laporte (A)

Santé publique France, Saint-Maurice, France.

Patrick Rolland (P)

Santé publique France, Saint-Maurice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH